Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals

• Egile Nagusiak: Ruxing Zhao (Egilea), Yujing Sun (Egilea), Yongyuan Zhang (Egilea), Weili Wang (Egilea), Shouyu Wang (Egilea), Chuang Wang (Egilea), Jinbo Liu (Egilea), Ling Gao (Egilea), Zhao Hu (Egilea), Jianchun Fei (Egilea), Xinguo Hou (Egilea), Huizhen Zheng (Egilea), Li Chen (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2020-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background. COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has threatened every civilian as a global pandemic. The immune system poses the critical interactive chain between the human body and the virus. Here, we make efforts to examine whether comorbidity with type...